title: Prevalence, detection, and management of the metabolic syndrome in patients with acute myocardial infarction: role of an obesity-centric definition.
abstract: Background. We sought to determine and compare the prevalence of the Metabolic Syndrome (MS) in patients with acute myocardial infarction (AMI) utilizing the new International Diabetes Federation (IDF) definition with the older National Cholesterol Education Program (NCEP) definition. We also examined the clinical utility of MS in this context. Methods. A total of 107 consecutive patients with AMI were prospectively evaluated for MS. Fasting lipids obtained at admission and fasting glucose at discharge were used. A postdischarge folder audit verified rates of discharge coding and implementation of specific management strategies for MS. Results. Baseline patient characteristics included: mean age 59 +/- 13 years; males 80%; diabetes 19%; mean BMI 29.7 +/- 8.4 kg/m(2). MS prevalence was 54% by the IDF definition and 49% by the NCEP definition, with good agreement between definitions: kappa = 0.664, P < .001. Factors predictive of MS after multivariate analysis included: hypertension, fasting glucose, waist circumference, and serum HDL (all P < .05). Despite the high prevalence, MS was recognized at discharge in only 1 patient, and referral for exercise and/or weight-loss programs was undertaken in 5 patients. Conclusion. There is a high prevalence of MS utilizing contemporary definitions in patients with AMI: 54% by the IDF definition and 49% by NCEP criteria. Despite the high prevalence, MS was under-recognized and under-treated in this population.
authors.affiliation: Monash Heart and Monash Cardiovascular Research Centre, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne, Victoria 3168, Australia.
authors.forename: Sandhir B
authors.initials: SB
authors.lastname: Prasad
authors.forename: Farzan
authors.initials: F
authors.lastname: Fahrtash
authors.forename: Yuvaraj
authors.initials: Y
authors.lastname: Malaiapan
authors.forename: Ian T
authors.initials: IT
authors.lastname: Meredith
authors.forename: James
authors.initials: J
authors.lastname: Cameron
references.citation: Diabetes Res Clin Pract. 2007 Sep;77(3):471-8
references.pmid: 17350710
references.citation: Lancet. 2005 Sep 24-30;366(9491):1059-62
references.pmid: 16182882
references.citation: Med J Aust. 2006 Apr 17;184(S8):S1-S32
references.pmid: 16618231
references.citation: J Clin Endocrinol Metab. 2005 Jan;90(1):175-80
references.pmid: 15509644
references.citation: Am J Cardiol. 2002 Feb 15;89(4):460-2
references.pmid: 11835930
references.citation: Diabetes Care. 2001 Apr;24(4):683-9
references.pmid: 11315831
references.citation: J Am Coll Cardiol. 2004 Aug 4;44(3):671-719
references.pmid: 15358045
references.citation: BMJ. 2008 Mar 22;336(7645):640
references.pmid: 18356231
references.citation: Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36
references.pmid: 18174459
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: Diabet Med. 2006 May;23(5):469-80
references.pmid: 16681555
references.citation: Circulation. 2007 Apr 3;115(13):1806-10; discussion 1811
references.pmid: 17404171
references.citation: Diabetes Care. 2004 Jan;27 Suppl 1:S15-35
references.pmid: 14693923
references.citation: Am J Cardiol. 2007 Oct 1;100(7):1052-5
references.pmid: 17884360
references.citation: Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1651-3
references.pmid: 6439361
references.citation: Diabetes Care. 2003 Oct;26(10):2770-6
references.pmid: 14514578
references.citation: Diabetes Res Clin Pract. 2008 Jan;79(1):91-6
references.pmid: 17919764
references.citation: N Z Med J. 2006 Dec 15;119(1247):U2372
references.pmid: 17195862
references.citation: Circulation. 2004 Sep 7;110(10):1251-7
references.pmid: 15326061
references.citation: Diabetes. 1988 Dec;37(12):1595-607
references.pmid: 3056758
references.citation: World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
references.pmid: 11234459